Last updated: 2026-09-16 09:46:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
IO Biotech, Inc. (IOBT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
IO Biotech, Inc. (IOBT) is trading at $-- in pre-market trading as of --, -- from the previous close of $--
Pre-market trading shows how investors are pricing IOBT before the regular session opens. The current pre-market price is -- the previous close, indicating -- early trading sentiment.
Over the past seven days, IO Biotech, Inc. (IOBT) moved from $0,20 to $0,05, representing a decline of 76,00% ($0,15).
The stock traded between $0,03 and $0,21 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 89,88 million shares, up versus the previous seven-day period, indicating higher trading activity.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 78 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of IO Biotech, Inc. (IOBT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.